Explorer les evidences

10 175 EU/mLGeometric mean titres of IgG antibodies to the circumsporozoite antigen in infants were 10175 (7724 to 13404) EU/mL at day 84.

Kenyapaludismepublié 2023Wellcome open researcheurope_pmcdocument de 3 observations

1 500 000 deaths_per_yearMalaria kills between 1 and 2 million people each year.

Kenyapaludismepublié 2002Natureeurope_pmc

2 per_habitatThe mean density of An. squamosus was 2.0 in tire tracks in Kakamega County, western Kenya between March and June 2019.

Kenyapaludismeobservé March and June 2019publié 2021Ethiopian journal of health sciencesPubMeddocument de 8 observations

3 daysThe mean length of stay for patients admitted with a malaria diagnosis was three days.

Kenyapaludismeobservé June 2016 to May 2017publié 2021Malaria journalPubMeddocument de 11 observations

No resistant mutations in Pfk13 were found in Plasmodium falciparum parasites from Asembo, Kenya.

Kenyapaludismepublié 2022Malaria journalPubMeddocument de 10 observations

-0,718 correlation_coefficientHaematocrit correlated negatively with red cell distribution width in malaria-infected children with HbSS genotype (r = -0.718, P = 0.009).

Kenyapaludismepublié 2021BMC infectious diseasesPubMeddocument de 13 observations

4,09 odds_ratioHighland residents who had traveled were more likely to have Plasmodium infection at the time of interview than highland residents who had not traveled, with an adjusted odds ratio of 4.09.

Kenyapaludismeobservé 2015publié 2022Travel medicine and infectious diseasePubMeddocument de 3 observations

44,1 %The secondary endpoint of receipt of antimalarial treatment in the presence of parasitaemia of any density was reached in 49/111 (44.1%) non-Dantu subjects.

Kenyapaludismepublié 2022Controlled Human Malaria Infection reveals that the Dantu blood group variant provides higeurope_pmcdocument de 6 observationsDOI 10.1101/2022.09.21.22280031

21 deathsThe risk of dying between the ages of 5 years and 10 years was no higher among children who had received chemoprophylaxis with Maloprim than among children who had received placebo, with 21 deaths in the Maloprim group and 24 deaths in the placebo group.

Kenyapaludismepublié 1995Transactions of the Royal Society of Tropical Medicine and Hygieneeurope_pmcdocument de 3 observations

1,3 %Pfs25 exhibited low mutation frequencies ranging from 1.3% to 7.7%.

Kenyapaludismepublié 2022PloS onePubMeddocument de 6 observations

1 US dollars_per_person_per_yearInternational malaria funding allocation is less than US$1 per person at risk per year.

Kenyapaludismepublié 2008PLoS medicineeurope_pmcdocument de 5 observations

0,74 aIRRStandard LLINs plus annual IRS was more effective than standard LLINs alone at 1-6 months post-intervention (adjusted incidence rate ratio 0.74).

Kenyapaludismepublié 2026The Lancet. Global healthPubMeddocument de 8 observations

5 000 000 000 clinical_episodes_per_yearAlmost 5 billion clinical episodes resembling malaria occur in endemic areas annually.

Kenyapaludismepublié 2006Conquering Malariaeurope_pmcdocument de 6 observations

1,7 %Pfk13 A675V mutation associated with artemisinin resistance was present as mixed genotype infections in 2 samples (1.7%) among primary school-going children in 15 counties in Kenya.

Kenyapaludismepublié 2025BMC infectious diseasesPubMeddocument de 6 observations

13 false_negativesAt Siaya County Referral Hospital, there were 13 false negatives by routine microscopy compared to malachite green loop-mediated isothermal amplification (MG-LAMP).

Kenyapaludismepublié 2020Malaria journalPubMeddocument de 17 observations

91,7 %The use of the four-tests panel improved data management for the four infections by 91.7% in selected Primary Health Care facilities in Kenya.

Kenyahépatite B · paludisme · syphilis · VIH/sidapublié 2024Frontiers in public healthPubMeddocument de 15 observations

22 %The K65Q mutant allele was detected at a frequency of 22% in recurrent malaria infection samples.

Kenyapaludismepublié 2023Malaria journalPubMeddocument de 5 observations

0,89 aIRRAdding annual IRS to PBO nets was more effective than supplementing with larviciding at 13-18 months post-intervention among stage 1 non-responding clusters (adjusted incidence rate ratio 0.89).

Kenyapaludismepublié 2026The Lancet. Global healthPubMeddocument de 8 observations

19,7 %Infection prevalence was 19.7% in cross-sectional mass blood screening of children aged 5 to 15 years in Chulaimbo, Kisumu, during the dry and wet seasons in 2018 and 2019.

Kenyapaludismeobservé 2018 and 2019publié 2025Scientific reportsPubMeddocument de 10 observations

25 %The conclusion states that in settings typical of sub-Saharan Africa, one-quarter of WHO-defined pneumonia cases are malaria rather than pneumonia.

Kenyapaludismepublié 2025International journal of epidemiologyeurope_pmcdocument de 8 observations

1,12 mortality_rate_ratioIncrease in rainfall was associated with increased malaria mortality (mortality rate ratio = 1.12, 95% Bayesian credible interval: 1.04–1.20).

Kenyapaludismeobservé 2008–2019publié 2024BMJ global healthPubMeddocument de 8 observations

14 false_positivesAt Rota Dispensary, there were 14 false positives and 29 false negatives by rapid diagnostic test (RDT) compared to malachite green loop-mediated isothermal amplification (MG-LAMP).

Kenyapaludismepublié 2020Malaria journalPubMeddocument de 17 observations

44 %The introduction of insecticide treated bednets led to a 44% reduction in severe, life-threatening malaria among children aged 1-59 months.

Kenyapaludismeobservé 1993–1995publié 1996Tropical medicine & international health : TM & IHeurope_pmcdocument de 3 observations

33 %The introduction of insecticide treated bednets led to a 33% reduction in childhood mortality among children aged 1-59 months.

Kenyapaludismeobservé 1993–1995publié 1996Tropical medicine & international health : TM & IHeurope_pmcdocument de 3 observations

EDCTP funds clinical trial interventions to fight HIV/AIDS, malaria, and tuberculosis in the sub-Saharan African region.

Kenyapaludisme · tuberculose · VIH/sidapublié 2009BMC public healtheurope_pmcdocument de 4 observationsDOI 10.1186/1471-2458-9-249